SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

SEC Comment Letter 0000000000-24-004497 to Bloomin' Brands, Inc. (BLMN) (CIK 0001546417) (BLMN)

Bloomin' Brands, Inc. (BLMN) (CIK 0001546417)
Date: April 23, 2024 · CIK: 0001546417 · Accession: 0000000000-24-004497

AI Filing Summary & Sentiment

Date
April 23, 2024
Author
Not clearly detected
Form
UPLOAD
Company
Bloomin' Brands, Inc. (BLMN) (CIK 0001546417)

Letter

United States securities and exchange commission logo April 23, 2024 Christopher Meyer Chief Financial Officer Bloomin' Brands, Inc. 2202 North West Shore Boulevard, Suite 500 Tampa, FL 33607 Re:Bloomin' Brands, Inc. Form 10-K for the Fiscal Year Ended December 31, 2023 Filed February 28, 2024 File No. 1-35625 Dear Christopher Meyer: We have reviewed your filing and have the following comment(s). Please respond to this letter within ten business days by providing the requested information or advise us as soon as possible when you will respond. If you do not believe a comment applies to your facts and circumstances, please tell us why in your response. After reviewing your response to this letter, we may have additional comments. Form 10-K for the Fiscal Year Ended December 31, 2023 Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations Adjusted Net Income and Adjusted Diluted Earnings Per Share Non-GAAP Reconciliations, page 48 1.In your calculation of adjusted diluted earnings per share you exclude the dilutive effect of 5,077 and 6,089 shares for 2023 and 2022, respectively, to be issued upon conversion of the 2025 Notes since your convertible note hedge offsets the dilutive impact of the shares. On page 80, you state that the convertible note hedge transactions are not considered when calculating dilutive shares given their antidilutive impact as an offset to dilution of shares underlying the 2025 Notes. Please tell us how you concluded that the noted adjustment does not represent an individually tailored accounting principle. Refer to Question 100.04 of the Non-GAAP Financial Measures Compliance and Disclosure Interpretations.

FirstName LastNameChristopher Meyer Comapany NameBloomin' Brands, Inc. April 23, 2024 Page 2 FirstName LastName Christopher Meyer Bloomin' Brands, Inc. April 23, 2024 Page 2 We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tony Watson at 202-551-3318 or Joel Parker at 202-551-3651 if you have questions regarding comments on the financial statements and related matters. Sincerely, Division of Corporation Finance Office of Trade & Services

Show Raw Text
United States securities and exchange commission logo
April 23, 2024
Christopher Meyer
Chief Financial Officer
Bloomin' Brands, Inc.
2202 North West Shore Boulevard, Suite 500
Tampa, FL 33607
Re:Bloomin' Brands, Inc.
Form 10-K for the Fiscal Year Ended December 31, 2023
Filed February 28, 2024
File No. 1-35625
Dear Christopher Meyer:
            We have reviewed your filing and have the following comment(s).
            Please respond to this letter within ten business days by providing the requested
information or advise us as soon as possible when you will respond. If you do not believe a
comment applies to your facts and circumstances, please tell us why in your response.
            After reviewing your response to this letter, we may have additional comments.
Form 10-K for the Fiscal Year Ended December 31, 2023
Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations
Adjusted Net Income and Adjusted Diluted Earnings Per Share Non-GAAP Reconciliations,
page 48
1.In your calculation of adjusted diluted earnings per share you exclude the dilutive effect of
5,077 and 6,089 shares for 2023 and 2022, respectively, to be issued upon conversion of
the 2025 Notes since your convertible note hedge offsets the dilutive impact of the shares.
On page 80, you state that the convertible note hedge transactions are not considered when
calculating dilutive shares given their antidilutive impact as an offset to dilution of shares
underlying the 2025 Notes. Please tell us how you concluded that the noted adjustment
does not represent an individually tailored accounting principle. Refer to Question 100.04
of the Non-GAAP Financial Measures Compliance and Disclosure Interpretations.

 FirstName LastNameChristopher Meyer
 Comapany NameBloomin' Brands, Inc.
 April 23, 2024 Page 2
 FirstName LastName
Christopher Meyer
Bloomin' Brands, Inc.
April 23, 2024
Page 2
            We remind you that the company and its management are responsible for the accuracy
and adequacy of their disclosures, notwithstanding any review, comments, action or absence of
action by the staff.
            Please contact Tony Watson at 202-551-3318 or Joel Parker at 202-551-3651 if you have
questions regarding comments on the financial statements and related matters.
Sincerely,
Division of Corporation Finance
Office of Trade & Services